Journal of Chinese Integrative Medicine ›› 2008, Vol. 6 ›› Issue (9): 907-910.doi: 10.3736/jcim20080906
• Original Clinical Research • Previous Articles Next Articles
Effects of Jinlong Capsule on expressions of interleukin-2 and soluble interleukin-2 receptor in patients with primary liver cancer after transarterial chemoembolization therapy
Huo-jun Zhang, Ji-jin Yang(
), Wei-xing Wang, Xu Jiang, Yan-jun Mao, Chao-ai Yang, Ji-xiang Guo
- Department of Radiology, Changhai Hospital, Second Military Medical University, Shanghai 200433, China
CLC Number:
- R735.7
| [1] | El-Shanawani FM, Abdel-Hadi AA, Abu Zikri NB , et al. Clinical significance of aflatoxin, mutant P53 gene and sIL-2 receptor in liver cirrhosis and hepatocellular carcinoma[J]. Egypt Soc Parasitol, 2006,36(1):221-239 |
| [2] |
Handzel ZT, Barak V, Altman Y , et al. Increased Th1 and Th2 type cytokine production in patients with active tuberculosis[J]. Isr Med Assoc J, 2007,9(6):479-483
doi: 10.1007/s11845-007-0023-0 pmid: 17642401 |
| [3] |
Sandberg JK, Moll M . Effects of interleukin-2 treatment on CD1d-restricted natural killer T cells[J]. Clin Cancer Res, 2007,13(14):4311-4315
doi: 10.1158/1078-0432.CCR-07-1267 pmid: 17634562 |
| [4] |
Garrod KR, Wei SH, Parker I , et al. Natural killer cells actively patrol peripheral lymph nodes forming stable conjugates to eliminate MHC-mismatched targets[J]. Proc Natl Acad Sci U S A, 2007,104(29):12081-12086
doi: 10.1073/pnas.0702867104 |
| [5] |
Porta C, Paglino C, Imarisio I , et al.Cytokine-based immunotherapy for advanced kidney cancer: past results and future perspectives in the era of molecularly targeted agents[J].ScientificWorldJournal, 2007, 7: 837-849
doi: 10.1100/tsw.2007.154 |
| [6] |
Barker SE, Grosse SM, Siapati EK , et al. Immunotherapy for neuroblastoma using syngeneic fibroblasts transfected with IL-2 and IL-12[J]. Br J Cancer, 2007,97(2):210-217
doi: 10.1038/sj.bjc.6603857 pmid: 2360308 |
| [7] |
Ottaiano A, Leonardi E, Simeone E , et al. Soluble interleukin-2 receptor in stage I-III melanoma[J]. Cytokine, 2006,33(3):150-155
doi: 10.1016/j.cyto.2006.01.002 pmid: 16517174 |
| [8] |
Izzo F, Cremona F, Delrio P , et al. Soluble interleukin-2 receptor levels in hepatocellular cancer: a more sensitive marker than alfa fetoprotein[J]. Ann Surg Oncol, 1999,6(2):178-185
doi: 10.1007/s10434-999-0178-1 |
| [9] |
Parasole R, Izzo F, Perrone F , et al. Prognostic value of serum biological markers in patients with hepatocellular carcinoma[J]. Clin Cancer Res, 2001,7(11):3504-3509
doi: 10.1093/carcin/22.11.1891 pmid: 11705869 |
| [10] | Kobayashi R, Yoshimatsu K, Yokomizo H , et al. Low-dose chemotherapy with leucovorin plus 5-fluorouracil for colorectal cancer can maintain host immunity[J]. Anticancer Res, 2007,27(1B):675-679 |
| [11] |
Jia LQ, Li X, Wan DG , et al. The effectiveness of two-way immune modulation of Jinlong Capsules in SARS patients[J]. Beijing Yi Xue, 2005,27(9):550-552
doi: 10.3969/j.issn.0253-9713.2005.09.013 |
|
贾立群, 李学, 万冬桂 , 等. 金龙胶囊的免疫双向调节作用[J]. 北京医学, 2005,27(9):550-552
doi: 10.3969/j.issn.0253-9713.2005.09.013 |
|
| [12] | Qiu FB, Wu LQ, Lu Y , et al. Predominant expression of Th1-type cytokines in primary hepatic cancer and adjacent liver tissues[J]. Hepatobiliary Pancreat Dis Int, 2007,6(1):63-66 |
| [13] |
Ishiyama K, Ohdan H, Ohira M , et al. Difference in cytotoxicity against hepatocellular carcinoma between liver and periphery natural killer cells in humans[J]. Hepatology, 2006,43(2):362-372
doi: 10.1002/(ISSN)1527-3350 |